CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 96 filers reported holding CYTOSORBENTS CORP in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,000 | -45.8% | 10,129 | -8.0% | 0.00% | – |
| Q2 2022 | $24,000 | -29.4% | 11,014 | +0.4% | 0.00% | – |
| Q1 2022 | $34,000 | -32.0% | 10,969 | -8.8% | 0.00% | – |
| Q4 2021 | $50,000 | -63.0% | 12,023 | -27.8% | 0.00% | – |
| Q3 2021 | $135,000 | -4.9% | 16,659 | -12.0% | 0.00% | – |
| Q2 2021 | $142,000 | -4.7% | 18,923 | +10.1% | 0.00% | – |
| Q1 2021 | $149,000 | +9.6% | 17,185 | 0.0% | 0.00% | – |
| Q4 2020 | $136,000 | -0.7% | 17,185 | 0.0% | 0.00% | – |
| Q3 2020 | $137,000 | -12.2% | 17,185 | +8.9% | 0.00% | -100.0% |
| Q2 2020 | $156,000 | +26.8% | 15,785 | -1.3% | 0.00% | 0.0% |
| Q1 2020 | $123,000 | +101.6% | 15,985 | 0.0% | 0.00% | – |
| Q4 2019 | $61,000 | -23.8% | 15,985 | 0.0% | 0.00% | – |
| Q3 2019 | $80,000 | -32.2% | 15,985 | -11.1% | 0.00% | -100.0% |
| Q2 2019 | $118,000 | -11.3% | 17,985 | +1.7% | 0.00% | 0.0% |
| Q1 2019 | $133,000 | -10.1% | 17,685 | -4.1% | 0.00% | 0.0% |
| Q4 2018 | $148,000 | -38.3% | 18,435 | -1.1% | 0.00% | 0.0% |
| Q3 2018 | $240,000 | +20.6% | 18,635 | +6.9% | 0.00% | 0.0% |
| Q2 2018 | $199,000 | – | 17,435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |